These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31937331)

  • 1. Aberrant DNA methylation profile exacerbates inflammation and neurodegeneration in multiple sclerosis patients.
    Celarain N; Tomas-Roig J
    J Neuroinflammation; 2020 Jan; 17(1):21. PubMed ID: 31937331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
    Hauser SL; Oksenberg JR
    Neuron; 2006 Oct; 52(1):61-76. PubMed ID: 17015227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis.
    Celarain N; Tomas-Roig J
    Front Genet; 2019; 10():1138. PubMed ID: 31798633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Genetic and Epigenetic Basis of Multiple Sclerosis.
    Hojati Z
    Adv Exp Med Biol; 2017; 958():65-90. PubMed ID: 28093709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in Multiple Sclerosis.
    Chan VS
    Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation: a New Player in Multiple Sclerosis.
    Li X; Xiao B; Chen XS
    Mol Neurobiol; 2017 Aug; 54(6):4049-4059. PubMed ID: 27314687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of multiple sclerosis: an updated review.
    Küçükali Cİ; Kürtüncü M; Çoban A; Çebi M; Tüzün E
    Neuromolecular Med; 2015 Jun; 17(2):83-96. PubMed ID: 24652042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modifications and Therapy in Multiple Sclerosis.
    Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
    Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in Multiple Sclerosis: Molecular Mechanisms and Dietary Intervention.
    Rito Y; Torre-Villalvazo I; Flores J; Rivas V; Corona T
    Cent Nerv Syst Agents Med Chem; 2018 Jan; 18(1):8-15. PubMed ID: 26915659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
    Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
    Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
    Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
    Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
    Stadelmann C; Wegner C; Brück W
    Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA Methylation Profile of CD14+ Monocytes Changes in Primary Progressive Multiple Sclerosis].
    Kiselev IS; Kulakova OG; Baturina OA; Kabilov MR; Boyko AN; Favorova OO
    Mol Biol (Mosk); 2023; 57(5):819-826. PubMed ID: 37752647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
    Dulamea AO
    Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tale of histone modifications and its role in multiple sclerosis.
    He H; Hu Z; Xiao H; Zhou F; Yang B
    Hum Genomics; 2018 Jun; 12(1):31. PubMed ID: 29933755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Sclerosis Pathology.
    Lassmann H
    Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic insights into multiple sclerosis disease progression.
    Kular L; Jagodic M
    J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.